BACKGROUND: Infectious complications, especially febrile neutropenia, in hemato-oncological patients are associated with considerable morbidity, mortality and expenses. Remote monitoring of physiological functions and thus early detection of adverse events via telemedicine could improve the safety of these high-risk patients and save financial resources by shortening the time-to-antibiotics. METHODS: Patients undergoing active cancer treatment in high risk of acquiring severe infection are selected and enrolled in this project. Each patient receives a digital blood pressure monitor, an infrared thermometer and a mobile hub (cell phone). In the comfort of their homes, patients measure their blood pressure/pulse and body temperature regularly or whenever they feel unwell. The obtained data are encrypted and forwarded via the mobile hub to the password-protected portal. The values registered outside the set-up range trigger the alarms, which are immediately sent to the designated physician who can check the portal in real-time from any device with an Internet connection, contact the patient, if need be, and initiate the anti-infective therapy almost instantly after the first symptoms occur. RESULTS: Fifty hemato-oncological patients were recruited between March 1, 2018 and August 1, 2020. Two hundred ninety-seven alarms of body temperature were registered and checked by the physician and patients were contacted in 18.5% of the cases (55/297). Among these 55 events, 13 required medical assistance, which makes it approximately one-quarter of all conducted telephone interventions (23.4%) and neither septic shock nor death due to treatment-related toxicity occurred. CONCLUSION: Telemedicine seems like a useful tool to improve the safety of high risk hemato-oncological patients when treatment-related infectious complications are concerned.

Department of Haematooncology University Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic

Faculty of Science University of Ostrava Ostrava Czech Republic

National Monitoring Center Ostrava Czech Republic

Zobrazit více v PubMed

Harris J, Cheevers K, Armes J. The emerging role of digital health in monitoring and supporting people living with cancer and the consequences of its treatments. Curr Opin Support Palliat Care. 2018;12(3):268–275. doi:10.1097/SPC.0000000000000362 PubMed DOI

Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book. 2018;38:540–545. doi:10.1200/EDBK_200141 PubMed DOI

Hanlon P, Daines L, Campbell C, McKinstry B, Weller D, Pinnock H. Telehealth interventions to support self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res. 2017;19(5):e172. doi:10.2196/jmir.6688 PubMed DOI PMC

Klastersky J, de Naurois J, Rolston K, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016;27:v111–v118. doi:10.1093/annonc/mdw325 PubMed DOI

White L, Ybarra M. Neutropenic fever. Emerg Med Clin North Am. 2014;32(3):549–561. doi:10.1016/j.emc.2014.04.002 PubMed DOI

Ko BS, Ahn S, Lee YS, Kim WY, Lim KS, Lee JL. Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia. Support Care Cancer. 2015;23(9):2799–2804. doi:10.1007/s00520-015-2645-5 PubMed DOI

Rosa RG, Goldani LZ. Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother. 2014;58(7):3799–3803. doi:10.1128/AAC.02561-14 PubMed DOI PMC

Ko HF, Tsui SS, Tse JWK, Kwong WY, Chan OY, Wong GCK. Improving the emergency department management of post-chemotherapy sepsis in haematological malignancy patients. Hong Kong Med J. 2015;21(1):10–15. doi:10.12809/hkmj144280 PubMed DOI

Bruthans J. ePACS - (neprávem) “ten druhý vzadu.”. Med Tribune. 2019;15(5):A6–A6.

Battineni G, Nittari G, Sirignano A, Amenta F. Are telemedicine systems effective healthcare solutions during the COVID-19 pandemic? J Taibah Univ Med Sci. 2021;16(3):305–306. doi:10.1016/j.jtumed.2021.02.009 PubMed DOI PMC

Battineni G, Pallotta G, Nittari G, Amenta F. Telemedicine framework to mitigate the impact of the COVID-19 pandemic. J Taibah Univ Med Sci. 2021;16(2):300–302. doi:10.1016/j.jtumed.2020.12.010 PubMed DOI PMC

Pareek P, Vishnoi JR, Kombathula SH, Vyas RK, Misra S. Teleoncology: the youngest pillar of oncology. JCO Glob Oncol. 2020;6:1455–1460. doi:10.1200/GO.20.00295 PubMed DOI PMC

Cox A, Lucas G, Marcu A, et al. Cancer survivors’ experience with telehealth: a systematic review and thematic synthesis. J Med Internet Res. 2017;19(1):e11. doi:10.2196/jmir.6575 PubMed DOI PMC

Ho A, Quick O. Leaving patients to their own devices? Smart technology, safety and therapeutic relationships. BMC Med Ethics. 2018;19. doi:10.1186/s12910-018-0255-8 PubMed DOI PMC

Yildiz F, Oksuzoglu B. Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors? Future Oncol.2020. 16(28):2191–2195. doi:10.2217/fon-2020-0714 PubMed DOI PMC

Cox SM, Lane A, Volchenboum SL. Use of wearable, mobile, and sensor technology in cancer clinical trials. JCO Clin Cancer Inf. 2018;(2):1–11. doi:10.1200/CCI.17.00147 PubMed DOI

Fox P, Darley A, Furlong E, et al. The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin’s and non-Hodgkin’s lymphomas: a scoping review. Eur J Oncol Nurs. 2017;26:63–82. doi:10.1016/j.ejon.2016.12.008 PubMed DOI

Maguire R, Fox PA, McCann L, et al. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer. BMJ Open. 2017;7(5):e015016. doi:10.1136/bmjopen-2016-015016 PubMed DOI PMC

Maguire R, McCann L, Kotronoulas G, et al. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ. 2021;374:n1647. doi:10.1136/bmj.n1647 PubMed DOI PMC

Breen S, Ritchie D, Schofield P, et al. The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial. Trials. 2015;16:472. doi:10.1186/s13063-015-0970-0 PubMed DOI PMC

Moradian S, Krzyzanowska M, Maguire R, et al. Feasibility randomised controlled trial of remote symptom chemotherapy toxicity monitoring using the Canadian adapted Advanced Symptom Management System (ASyMS-Can): a study protocol. BMJ Open. 2020;10(6):e035648. doi:10.1136/bmjopen-2019-035648 PubMed DOI PMC

Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557–565. doi:10.1200/JCO.2015.63.0830 PubMed DOI PMC

Rico TM, Dos Santos Machado K, Fernandes VP, et al. Use of text messaging (SMS) for the management of side effects in cancer patients undergoing chemotherapy treatment: a randomized controlled trial. J Med Syst. 2020;44(11). doi:10.1007/s10916-020-01663-x PubMed DOI PMC

Simblett S, Greer B, Matcham F, et al. Barriers to and facilitators of engagement with remote measurement technology for managing health: systematic review and content analysis of findings. J Med Internet Res. 2018;20(7):e10480. doi:10.2196/10480 PubMed DOI PMC

An economic evaluation of the effectiveness of telemedicine in hematooncology